Stereotaxis, Inc. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>Stereotaxis, Inc. has filed its Definitive Proxy Statement (DEF 14A) for the fiscal year ending December 31, 2023, detailing executive compensation and equity award valuations.</b>

AI Summary

Stereotaxis, Inc. (STXS) filed a Proxy Statement (DEF 14A) with the SEC on April 4, 2024. Stereotaxis, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 4, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal executive offices are located at 710 N Tucker Blvd, Ste 110, St. Louis, MO 63101. The filing includes detailed information regarding executive compensation and equity awards. Specific data points relate to the fair value of equity awards for both PEO and Non-PEO members for the fiscal years 2022 and 2023.

Why It Matters

For investors and stakeholders tracking Stereotaxis, Inc., this filing contains several important signals. This filing provides shareholders with crucial information regarding the company's governance and executive compensation practices, enabling informed voting decisions. The detailed breakdown of equity award valuations is important for understanding potential dilution and the alignment of executive incentives with shareholder value.

Risk Assessment

Risk Level: low — Stereotaxis, Inc. shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate disclosure rather than an event-driven filing that might signal higher risk.

Analyst Insight

Review the executive compensation details and equity award valuations to assess management's alignment with shareholder interests.

Key Numbers

• 2023-12-31 — Fiscal Year End (Period covered by the filing)
• 2024-04-04 — Filing Date (Date the DEF 14A was filed)

Key Players & Entities

• Stereotaxis, Inc. (company) — Filer of the DEF 14A
• DEF 14A (filing) — Type of SEC filing
• 2024-04-04 (date) — Filing date
• 2023-12-31 (date) — Fiscal year end
• 710 N TUCKER BLVD STE 110 (address) — Company business address
• ST.LOUIS (location) — Company city
• MO (location) — Company state
• 314-678-6100 (phone) — Company business phone

FAQ

Industry Context

Stereotaxis operates in the electromedical and electrotherapeutic apparatus industry, focusing on medical device technology.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to disclose information relevant to shareholders.

What Investors Should Do

1. Analyze the compensation structure for named executive officers.
2. Evaluate the fair value and changes in equity awards for PEO and Non-PEO members.
3. Review any proposals presented to shareholders for voting.

Key Dates

• 2024-04-04: Filing of DEF 14A — Official submission of proxy materials for the fiscal year 2023.

Year-Over-Year Comparison

This is the initial DEF 14A filing for the fiscal year 2023, following the previous year's filings.

Filing Documents

• formdef14a.htm (DEF 14A) — 668KB
• formdef14a_003.jpg (GRAPHIC) — 10KB
• formdef14a_004.jpg (GRAPHIC) — 86KB
• proxycard_001.jpg (GRAPHIC) — 173KB
• proxycard_002.jpg (GRAPHIC) — 149KB
• 0001493152-24-013167.txt (&nbsp;) — 2255KB
• stxs-20231231.xsd (EX-101.SCH) — 5KB
• stxs-20231231_def.xml (EX-101.DEF) — 9KB
• stxs-20231231_lab.xml (EX-101.LAB) — 62KB
• stxs-20231231_pre.xml (EX-101.PRE) — 43KB
• formdef14a_htm.xml (XML) — 73KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 15

Executive Compensation Summary and Analysis

Executive Compensation Summary and Analysis 15 Summary Compensation Table 18 Outstanding Equity Awards at Fiscal Year-End 19 Pay versus Performance 20 Securities Authorized for Issuance under Equity Compensation Plans 22

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 23 REPORT OF AUDIT COMMITTEE 24 PROPOSAL 1: ELECTION OF DIRECTORS 25 PROPOSAL 2: RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS 25 PROPOSAL 3: APPROVAL OF AN AMENDMENT TO THE STEREOTAXIS, INc. 2022 STOCK INCENTIVE PLAN 26 PROPOSAL 4: APPROVAL OF AN AMENDMENT TO THE 2022 EMPLOYEE STOCK PURCHASE PLAN 30 PRINCIPAL ACCOUNTING FEES AND SERVICES 34 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 35 DELINQUENT SECTION 16(a) REPORTS 35 GENERAL INFORMATION 35 APPENDIX A A-1 APPENDIX B B-1 3 QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING Q. Why am I receiving these materials? The Board of Directors (the "Board") of Stereotaxis, Inc. (the "Company") is soliciting proxies from the Company's shareholders in connection with its 2024 Annual Meeting of Shareholders to be held on May 15, 2024, and any and all adjournments and postponements thereof. You are encouraged to vote on the proposals presented in these proxy materials. You are invited to attend the Annual Meeting, but you do not have to attend to vote. Q. When and where is the Annual Meeting? We presently intend to hold the Annual Meeting of Shareholders on Wednesday, May 15, 2024, at 10:00 a.m. Central Daylight Time, at our principal executive offices located at 710 North Tucker Boulevard, Suite 110, St. Louis, MO 63101. Q. Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials? In accordance with rules adopted by the Securities and Exchange Commission (the "SEC"), we may furnish proxy materials, including this proxy statement and our 2023 Annual Report on Form 10-K, to our shareholders by providing access to such documents on the Internet instead of mailing printed copies. Most shareholders will not receive printed copies of the proxy materials unless they request them. Instead, the Notice, which was mailed to mos

View Full Filing

View this DEF 14A filing on SEC EDGAR